Andrea Granados
Pediatric Endocrinology · Miami, FLNPI 1073830204
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,780 of the $19,183 with a category attached, or 61.4%. 31 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 51.9% of the total. 2025 is the largest year on record at $8,915, more than ten times the $525 reported in 2021.
Across 171 payments — averaging $112.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$10K
- Sanofi$3K
- Mannkind Corporation$2K
- Insulet Corporation$600
- Novo Nordisk$366
- Sequel Med Tech, LLC$285
- plus $3K from 25 others
What the payments were for
- Consulting fees$11,78061%
- Speaking & faculty fees$2,12511%
- Food & beverage$5,26527%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 20 | $9,963 |
| Sanofi | 2 | $2,975 |
| Mannkind Corporation | 3 | $2,257 |
| Insulet Corporation | 16 | $600 |
| Novo Nordisk | 11 | $366 |
| Sequel Med Tech, LLC | 3 | $285 |
| Tandem Diabetes Care, Inc. | 9 | $264 |
| Dexcom, Inc. | 19 | $233 |
| Eton Pharmaceuticals, Inc. | 3 | $207 |
| AbbVie | 11 | $198 |
| Rhythm Pharmaceuticals, Inc. | 4 | $182 |
| Ascendis Pharma Endocrinology Inc | 7 | $180 |
| AstraZeneca | 4 | $173 |
| Ultragenyx Pharmaceutical Inc. | 3 | $169 |
| Xeris Pharmaceuticals, Inc. | 7 | $157 |
| Abbott | 7 | $152 |
| Lifescan, Inc. | 6 | $115 |
| BETA Bionics, Inc. | 7 | $114 |
| Kyowa Kirin, Inc. | 4 | $86 |
| Amneal Pharmaceuticals LLC | 4 | $64 |
| Zealand Pharma US, Inc. | 3 | $61 |
| Lilly USA, LLC | 3 | $59 |
| Neurocrine Biosciences, Inc. | 2 | $52 |
| Biomarin Pharmaceutical Inc. | 2 | $45 |
| Tolmar Pharmaceuticals, Inc. | 2 | $45 |
| Pfizer | 2 | $42 |
| Amryt Pharma Holdings Ltd | 2 | $39 |
| Medtronic | 2 | $33 |
| BD | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,183 in reported general payments places this provider in the 85th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Miami
- Alejandro DiazMiami$101K
- Adriana Carrillo-IreguiMiami$19K
- Janine SanchezMiami$18K
- Joshua TarkoffMiami$9K
- Luis Gonzalez-MendozaMiami$9K
- Omar BeckettMiami$4K
- Pedro Pagan BanchsMiami$4K
- Carmen Bustamante EscobarMiami$3K
- Jonanlis Ramirez AlcantaraMiami$2K
- Marco DanonMiami$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.